256 related articles for article (PubMed ID: 29511023)
1. Loss of
Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
Development; 2018 Mar; 145(6):. PubMed ID: 29511023
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
[TBL] [Abstract][Full Text] [Related]
3. MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.
Otsubo K; Goto H; Nishio M; Kawamura K; Yanagi S; Nishie W; Sasaki T; Maehama T; Nishina H; Mimori K; Nakano T; Shimizu H; Mak TW; Nakao K; Nakanishi Y; Suzuki A
Oncogene; 2017 Jul; 36(29):4201-4211. PubMed ID: 28346423
[TBL] [Abstract][Full Text] [Related]
4. YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity.
Yuan Y; Park J; Feng A; Awasthi P; Wang Z; Chen Q; Iglesias-Bartolome R
Nat Commun; 2020 Mar; 11(1):1472. PubMed ID: 32193376
[TBL] [Abstract][Full Text] [Related]
5. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
6. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
7. YAP1 negatively regulates chondrocyte differentiation partly by activating the β-catenin signaling pathway.
Yang B; Sun H; Song F; Yu M; Wu Y; Wang J
Int J Biochem Cell Biol; 2017 Jun; 87():104-113. PubMed ID: 28438716
[TBL] [Abstract][Full Text] [Related]
8. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
Nagashima S; Bao Y; Hata Y
Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
[TBL] [Abstract][Full Text] [Related]
9. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
[TBL] [Abstract][Full Text] [Related]
10. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
[TBL] [Abstract][Full Text] [Related]
11. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38813860
[TBL] [Abstract][Full Text] [Related]
12. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards AC; Stalnecker CA; Jean Morales A; Taylor KE; Klomp JE; Klomp JA; Waters AM; Sudhakar N; Hallin J; Tang TT; Olson P; Post L; Christensen JG; Cox AD; Der CJ
Cancer Res; 2023 Dec; 83(24):4112-4129. PubMed ID: 37934103
[TBL] [Abstract][Full Text] [Related]
13. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
Kodaka M; Hata Y
Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
[TBL] [Abstract][Full Text] [Related]
14. Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway.
Vanyai HK; Prin F; Guillermin O; Marzook B; Boeing S; Howson A; Saunders RE; Snoeks T; Howell M; Mohun TJ; Thompson B
Development; 2020 Nov; 147(21):. PubMed ID: 32994166
[TBL] [Abstract][Full Text] [Related]
15. RAP2 mediates mechanoresponses of the Hippo pathway.
Meng Z; Qiu Y; Lin KC; Kumar A; Placone JK; Fang C; Wang KC; Lu S; Pan M; Hong AW; Moroishi T; Luo M; Plouffe SW; Diao Y; Ye Z; Park HW; Wang X; Yu FX; Chien S; Wang CY; Ren B; Engler AJ; Guan KL
Nature; 2018 Aug; 560(7720):655-660. PubMed ID: 30135582
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers.
Kang W; Cheng AS; Yu J; To KF
World J Gastroenterol; 2016 Jan; 22(3):1279-88. PubMed ID: 26811664
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models.
Du W; Du W; Wan M; Zhou X; Xu X; Zheng L
Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766
[TBL] [Abstract][Full Text] [Related]
18. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.
Strnadel J; Choi S; Fujimura K; Wang H; Zhang W; Wyse M; Wright T; Gross E; Peinado C; Park HW; Bui J; Kelber J; Bouvet M; Guan KL; Klemke RL
Cancer Res; 2017 Apr; 77(8):1997-2007. PubMed ID: 28381547
[TBL] [Abstract][Full Text] [Related]
19. YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism.
Zhao L; Guan H; Song C; Wang Y; Liu C; Cai C; Zhu H; Liu H; Zhao L; Xiao J
Bone; 2018 May; 110():177-186. PubMed ID: 29432919
[TBL] [Abstract][Full Text] [Related]
20. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.
Song S; Ajani JA; Honjo S; Maru DM; Chen Q; Scott AW; Heallen TR; Xiao L; Hofstetter WL; Weston B; Lee JH; Wadhwa R; Sudo K; Stroehlein JR; Martin JF; Hung MC; Johnson RL
Cancer Res; 2014 Aug; 74(15):4170-82. PubMed ID: 24906622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]